Dronedarone reduces arterial thrombus formation-Reference-Cited by-同舟云学术

Dronedarone reduces arterial thrombus formation

Published:2012-09-29 Issue:6 Volume:107 Page:
ISSN:0300-8428
Container-title:Basic Research in Cardiology
language:en
Short-container-title:Basic Res Cardiol

Author:

Breitenstein Alexander,Sluka Susanna H. M.,Akhmedov Alexander,Stivala Simona,Steffel Jan,Camici Giovanni G.,Riem Huy H.,Beer Hans-Jurg,Studt Jan-Dirk,Duru Firat,Luscher Thomas F.,Tanner Felix C.

Publisher

Springer Science and Business Media LLC

Subject

Physiology (medical),Cardiology and Cardiovascular Medicine,Physiology

Link

http://link.springer.com/content/pdf/10.1007/s00395-012-0302-4.pdf

Reference26 articles.

1. Breitenstein A, Camici GG, Tanner FC (2009) Tissue factor: beyond coagulation in the cardiovascular system. Clin Sci 118:159–172. doi: 10.1042/CS20080622

2. Breitenstein A, Tanner FC, Luscher TF (2010) Tissue factor and cardiovascular disease: quo vadis? Circ J 74:3–12. doi: 10.1253/circj.CJ-09-0818

3. Bukowska A, Hammwohner M, Sixdorf A, Schild L, Wiswedel I, Rohl FW, Wolke C, Lendeckel U, Aderkast C, Bochmann S, Chilukoti RK, Mostertz J, Bramlage P, Goette A (2012) Dronedarone prevents microcirculatory abnormalities in the left ventricle during atrial tachypacing in pigs. Br J Pharmacol 166:964–980. doi: 10.1111/j.1476-5381.2011.01784.x

4. Camici GG, Steffel J, Akhmedov A, Schafer N, Baldinger J, Schulz U, Shojaati K, Matter CM, Yang Z, Luscher TF, Tanner FC (2006) Dimethyl sulfoxide inhibits tissue factor expression, thrombus formation, and vascular smooth muscle cell activation: a potential treatment strategy for drug-eluting stents. Circulation 114:1512–1521. doi: 10.1161/CIRCULATIONAHA.106.638460

5. Connolly SJ, Camm AJ, Halperin JL, Joyner C, Alings M, Amerena J, Atar D, Avezum A, Blomstrom P, Borggrefe M, Budaj A, Chen SA, Ching CK, Commerford P, Dans A, Davy JM, Delacretaz E, Di Pasquale G, Diaz R, Dorian P, Flaker G, Golitsyn S, Gonzalez-Hermosillo A, Granger CB, Heidbuchel H, Kautzner J, Kim JS, Lanas F, Lewis BS, Merino JL, Morillo C, Murin J, Narasimhan C, Paolasso E, Parkhomenko A, Peters NS, Sim KH, Stiles MK, Tanomsup S, Toivonen L, Tomcsanyi J, Torp-Pedersen C, Tse HF, Vardas P, Vinereanu D, Xavier D, Zhu J, Zhu JR, Baret-Cormel L, Weinling E, Staiger C, Yusuf S, Chrolavicius S, Afzal R, Hohnloser SH (2011) Dronedarone in high-risk permanent atrial fibrillation. N Engl J Med 365:2268–2276. doi: 10.1056/NEJMoa1109867

Cited by 7 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Incidence and Related Factors for Low-Extremity Deep Vein Thrombosis in Breast Cancer Patients Who Underwent Surgical Resection: What Do We Know and What Should We Care;Frontiers in Surgery;2022-02-04

2. Cardioprotective Effects of Dronedarone Mediated by the Influence on the Expression of Urokinase-Type Plasminogen Activator Receptor;Journal of Vascular Research;2019

3. Dronedarone exerts anticoagulant and antiplatelet effects independently of its antiarrhythmic actions;Atherosclerosis;2017-11

4. Dronedarone;Cardiac Electrophysiology Clinics;2016-06

5. Endosulfan activates the extrinsic coagulation pathway by inducing endothelial cell injury in rats;Environmental Science and Pollution Research;2015-06-02